{"id":3376,"date":"2026-03-23T10:45:23","date_gmt":"2026-03-23T07:45:23","guid":{"rendered":"https:\/\/ekonomievreni.com\/?p=3376"},"modified":"2026-03-23T10:45:24","modified_gmt":"2026-03-23T07:45:24","slug":"meme-kanseri-annelik-hayallerine-engel-degil","status":"publish","type":"post","link":"https:\/\/ekonomievreni.com\/?p=3376","title":{"rendered":"Meme kanseri annelik hayallerine engel de\u011fil"},"content":{"rendered":"

\u00dclkemizde gen\u00e7 ya\u015flarda da g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 artan meme kanserinde, son y\u0131llarda geli\u015ftirilen ak\u0131ll\u0131 ila\u00e7lar, imm\u00fcnoterapiler ve ki\u015fiye \u00f6zel tedavi yakla\u015f\u0131mlar\u0131, hastalar i\u00e7in umut veriyor.\u00a0Ac\u0131badem Ata\u015fehir Hastanesi T\u0131bbi Onkoloji Uzman\u0131 Prof. Dr. \u00d6zge G\u00fcm\u00fc\u015fay<\/strong>, do\u011fru zamanda ba\u015flanan tedaviyle hem ya\u015fam s\u00fcresinin hem de ya\u015fam kalitesinin \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131r\u0131labildi\u011fini belirterek \u201cEskiden meme kanseri denince hastalar ve yak\u0131nlar\u0131 i\u00e7in akla hemen umutsuz bir tablo gelirdi. Ama art\u0131k bu durum de\u011fi\u015fti; meme kanseri, t\u0131pk\u0131 diyabet ve hipertansiyon gibi uzun s\u00fcre kontrol alt\u0131nda tutulabilen bir hastal\u0131k haline geldi. Bu nedenle tan\u0131 alan hastalar\u0131m\u0131z\u0131n umutsuzlu\u011fa kap\u0131lmadan, alternatif y\u00f6ntemlere ba\u015fvurmadan onkoloji hekimine ba\u015fvurmas\u0131 ve tedavisine ba\u015flamas\u0131 b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor\u201d diyor. Prof. Dr. \u00d6zge G\u00fcm\u00fc\u015fay, meme kanseri tedavisinde yeni d\u00f6nemi anlatt\u0131, \u00f6nemli uyar\u0131lar ve \u00f6nerilerde bulundu.\u00a0<\/p>\n

Meme kanseri d\u00fcnyada ve \u00fclkemizde kad\u0131nlarda en s\u0131k g\u00f6r\u00fclen kanser t\u00fcr\u00fc olarak kar\u015f\u0131m\u0131za \u00e7\u0131k\u0131yor. Her y\u0131l milyonlarca kad\u0131n bu tan\u0131y\u0131 al\u0131rken, teknoloji ve t\u0131ptaki geli\u015fmeler sayesinde tedavi se\u00e7eneklerinin g\u00fc\u00e7lenmesi ise umutlar\u0131 art\u0131r\u0131yor.\u00a0Ac\u0131badem Ata\u015fehir Hastanesi T\u0131bbi Onkoloji Uzman\u0131 Prof. Dr. \u00d6zge G\u00fcm\u00fc\u015fay<\/strong>, hastalar\u0131n bu sayede ya\u015fam s\u00fcrelerinin uzad\u0131\u011f\u0131n\u0131 ve g\u00fcnl\u00fck ya\u015famlar\u0131n\u0131n kaliteli bir \u015fekilde devam edebildi\u011fini belirterek \u201c\u00d6zel bir teknolojiyle geli\u015ftirilen antikor-ila\u00e7 konjugatlar\u0131n\u0131n meme kanseri tedavisinde kullan\u0131ma girmesiyle \u00e7ok iyi sonu\u00e7lar elde edildi. Bu teknoloji sayesinde antikora ba\u011fl\u0131 olarak ta\u015f\u0131nan kemoterapi ilac\u0131 do\u011frudan kanser h\u00fccresine ula\u015ft\u0131r\u0131larak sa\u011fl\u0131kl\u0131 dokulara verilen zarar \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131labilmektedir. T\u00fcm hasta grubunun yakla\u015f\u0131k y\u00fczde 20\u2019sini olu\u015fturan HER2 pozitif meme kanserinde, damardan ba\u015flanan ak\u0131ll\u0131 ila\u00e7lar\u00a0sayesinde hastalar\u0131n t\u00fcm lezyonlar\u0131 gerileyerek hastal\u0131k kontrol\u00fc sa\u011flanarak uzun s\u00fcre ya\u015fam\u0131n\u0131 devam ettirebilmekteler. T\u00fcm vakalar\u0131n yakla\u015f\u0131k y\u00fczde 70\u2019ini olu\u015fturan \u00f6strojen duyarl\u0131 metastatik meme kanserli hastalar bazen sadece evde a\u011f\u0131zdan ald\u0131klar\u0131 ak\u0131ll\u0131 ila\u00e7lar ve endokrin tablet sayesinde kansersiz bir\u00a0\u015fekilde y\u0131llarca normal ya\u015fant\u0131lar\u0131n\u0131 s\u00fcrd\u00fcrebilmekteler\u201d diyor.\u00a0<\/p>\n

Ki\u015fiye \u00f6zel tedavi modeli<\/strong><\/p>\n

Son y\u0131llarda hedefe y\u00f6nelik ajanlar, antikor-ila\u00e7 konjugatlar\u0131 ve imm\u00fcnoterapi gibi yenilik\u00e7i tedavilerle meme kanseri tedavisinde \u00f6nemli bir d\u00f6n\u00fc\u015f\u00fcm ya\u015fand\u0131\u011f\u0131n\u0131 vurgulayan Prof. Dr. G\u00fcm\u00fc\u015fay s\u00f6zlerine \u015f\u00f6yle devam ediyor: \u201cArt\u0131k meme kanseri, tek bir hastal\u0131k olarak de\u011fil; biyolojik alt tiplerine ve molek\u00fcler \u00f6zelliklerine g\u00f6re ki\u015fiye \u00f6zel tedavi edilen bir hastal\u0131k olarak ele al\u0131nmaktad\u0131r. Bu nedenle tedavi karar\u0131n\u0131 verirken yaln\u0131zca t\u00fcm\u00f6r\u00fcn evresine de\u011fil, hormon resept\u00f6r durumuna, HER2 durumuna, genetik mutasyonlara, hastan\u0131n ya\u015f\u0131na, ek hastal\u0131klar\u0131na ve risk \u00f6zelliklerine g\u00f6re de\u011ferlendirme yap\u0131lmaktad\u0131r. Bug\u00fcn meme kanserinde amac\u0131m\u0131z herkese ayn\u0131 tedaviyi vermek de\u011fil; do\u011fru hastaya, do\u011fru zamanda, do\u011fru ilac\u0131 verebilmektir. Bu alanda devam eden bilimsel \u00e7al\u0131\u015fmalar\u0131n sonu\u00e7lar\u0131n\u0131 hem hastalar\u0131m\u0131z hem de biz onkologlar heyecanla takip ediyoruz. Tedavi se\u00e7eneklerinin her ge\u00e7en g\u00fcn artmas\u0131, meme kanseriyle m\u00fccadelede hem hastalar\u0131m\u0131za hem bizlere umut vermeye devam ediyor.\u201d<\/p>\n

Anne olmaya engel de\u011fil!<\/strong><\/p>\n

Meme kanserinin erken ya\u015flarda da g\u00f6r\u00fclebilen bir hastal\u0131k haline gelmesi ve son y\u0131llarda gen\u00e7 ya\u015flarda h\u0131zla yayg\u0131nla\u015fmas\u0131, meme kanseri tedavisi g\u00f6ren kad\u0131nlar\u0131, anne olmalar\u0131n\u0131 engelleyebilece\u011fi d\u00fc\u015f\u00fcncesiyle endi\u015felendiriyor. Prof. Dr. G\u00fcm\u00fc\u015fay bu konuda endi\u015feleri gideren bilimsel geli\u015fmeleri \u015f\u00f6yle anlat\u0131yor: \u201cHen\u00fcz \u00e7ocuk sahibi olmam\u0131\u015f ya da \u00e7ocuk iste\u011fi olan gen\u00e7 hastalar\u0131m\u0131z olup, bu hastalarda fertilite koruyucu yakla\u015f\u0131mlar b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r. Tedavi \u00f6ncesinde yumurta veya embriyo dondurma gibi y\u00f6ntemler planlanabilmekte; baz\u0131 hastalarda over bask\u0131lama tedavileri ile do\u011furganl\u0131\u011f\u0131n korunmas\u0131na katk\u0131 sa\u011flanabilmektedir. Yap\u0131lan \u00e7al\u0131\u015fma g\u00f6stermi\u015ftir ki kemoterapi ve radyoterapi tedavilerini tamamlayan hastalar\u0131m\u0131z, sonras\u0131nda yeterli s\u00fcre endokrin tedavisini al\u0131p (\u00e7al\u0131\u015fmada 18-30 ay endokrin tablet alm\u0131\u015flard\u0131) onkoloji doktorlar\u0131n\u0131n da onay\u0131 ile hamile kalmas\u0131na izin verilmekte. Meme kanseri tan\u0131l\u0131 hastalar takip eden onkoloji doktorunun \u00f6nerdi\u011fi\u00a0uygun zamanda gebe kald\u0131klar\u0131nda hastal\u0131\u011f\u0131n tekrarlama riski artmamaktad\u0131r, bu da yap\u0131lan \u00e7al\u0131\u015fma ile do\u011frulanm\u0131\u015ft\u0131r.\u201d\u00a0<\/p>\n

\u00d6te yandan meme kanseri olan hastalar\u0131n, ald\u0131klar\u0131 endokrin tedaviye ba\u011fl\u0131 yan etkiler ya\u015fayabildiklerini, bunlardan en \u00f6nemlisinin de s\u0131cak basmas\u0131 oldu\u011funu belirten Prof. Dr. G\u00fcm\u00fc\u015fay \u201cYap\u0131lan \u00e7al\u0131\u015fmada g\u00f6r\u00fcld\u00fc ki, s\u0131cak basmas\u0131 gibi ya\u015fam kalitesini bozan yan etkiye kar\u015f\u0131 geli\u015ftirilen ila\u00e7 sayesinde sorunun \u015fiddeti azald\u0131. FDA onay s\u00fcrecinin tamamlanmas\u0131n\u0131n ard\u0131ndan ilac\u0131n g\u00fcnl\u00fck prati\u011fe girmesi beklenmektedir\u201d diyor.\u00a0<\/p>\n

\u00dc\u00e7l\u00fc negatif meme kanserinde art\u0131k sonu\u00e7lar daha iyi\u00a0<\/strong><\/p>\n

\u00d6zellikle gen\u00e7 kad\u0131nlarda ve BRCA gen mutasyonu bulunan kad\u0131nlarda daha s\u0131k g\u00f6r\u00fclen \u00fc\u00e7l\u00fc negatif meme kanseri, t\u00fcm meme kanseri vakalar\u0131n\u0131n yakla\u015f\u0131k y\u00fczde 10-15\u2019ini olu\u015fturuyor. T\u0131bbi Onkoloji Uzman\u0131 Prof. Dr. \u00d6zge G\u00fcm\u00fc\u015fay, bu alt tipin ge\u00e7mi\u015fte daha agresif seyreden bir hastal\u0131k olarak de\u011ferlendirildi\u011fini belirtiyor.\u00a0<\/p>\n

\u00d6nceden sadece kemoterapi ile y\u00f6netilen bu alt tipte, imm\u00fcnoterapi ve yeni nesil antikor-ila\u00e7 konjugatlar\u0131 sayesinde tedavi ba\u015far\u0131s\u0131n\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015fti\u011fini vurgulayan Prof. Dr. G\u00fcm\u00fc\u015fay, \u015fu bilgileri veriyor: \u201cSon y\u0131llarda \u00fc\u00e7l\u00fc negatif meme kanseri tedavisinde iki \u00f6nemli geli\u015fme ya\u015fand\u0131. Bunlardan ilki imm\u00fcnoterapi, di\u011feri ise yeni nesil antikor-ila\u00e7 konjugatlar\u0131d\u0131r. Bu tedaviler sayesinde hastalarda tedavi ba\u015far\u0131s\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde artm\u0131\u015ft\u0131r. Erken evrede ameliyat \u00f6ncesi kemoterapiye imm\u00fcnoterapi eklenmesi art\u0131k standart tedavi olup \u00fclkemizde SGK \u00f6deme kapsam\u0131ndad\u0131r. Metastatik hastal\u0131kta ise \u00f6zellikle PD-L1 pozitif hastalarda imm\u00fcnoterapi \u00f6nemli fayda sa\u011flamaktad\u0131r\u201d\u00a0<\/p>\n

Ya\u015fam kalitesini art\u0131ran destek tedaviler<\/strong><\/p>\n

Tedavideki geli\u015fmelerin yaln\u0131zca kanseri hedeflemekle s\u0131n\u0131rl\u0131 kalmay\u0131p, hastalar\u0131n ya\u015fam kalitesini korumay\u0131 da ama\u00e7lad\u0131\u011f\u0131n\u0131 belirten T\u0131bbi Onkoloji Uzman\u0131 Prof. Dr. \u00d6zge G\u00fcm\u00fc\u015fay, \u015f\u00f6yle konu\u015fuyor: \u201cBulant\u0131 i\u00e7in geli\u015ftirilen ila\u00e7lar sayesinde bulant\u0131 ve kusma b\u00fcy\u00fck \u00f6l\u00e7\u00fcde kontrol alt\u0131na al\u0131nmaktad\u0131r. Enfeksiyona kar\u015f\u0131; kemoterapi sonras\u0131 uygulanan kan y\u00fckseltici i\u011fneler, grip a\u015f\u0131s\u0131, zat\u00fcrre a\u015f\u0131s\u0131 ve zona a\u015f\u0131s\u0131 gibi koruyucu \u00f6nlemler al\u0131nmaktad\u0131r. Sosyal ve psikolojik olarak s\u00fcreci zorla\u015ft\u0131ran sa\u00e7 d\u00f6k\u00fclmesine y\u00f6nelik kemoterapi s\u0131ras\u0131nda uygulanan -sa\u00e7l\u0131 deri so\u011futma i\u015flemleri- sa\u00e7 d\u00f6k\u00fclmesi \u00f6nemli \u00f6l\u00e7\u00fcde azalmakta ve hastalar\u0131n psikolojik y\u00fck\u00fcn\u00fc hafifletmektedir.\u201d<\/p>\n

\u00a0<\/p>\n

\u00a0<\/p>\n

Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00dclkemizde gen\u00e7 ya\u015flarda da g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131 artan meme kanserinde, son y\u0131llarda geli\u015ftirilen ak\u0131ll\u0131 ila\u00e7lar, imm\u00fcnoterapiler ve ki\u015fiye \u00f6zel tedavi yakla\u015f\u0131mlar\u0131, hastalar i\u00e7in umut veriyor.<\/p>\n","protected":false},"author":1,"featured_media":3377,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"class_list":["post-3376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3376"}],"version-history":[{"count":1,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3376\/revisions"}],"predecessor-version":[{"id":3378,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/posts\/3376\/revisions\/3378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=\/wp\/v2\/media\/3377"}],"wp:attachment":[{"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekonomievreni.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}